A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics

Patents for A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics (179,784)
11/2006
11/08/2006	CN1283599C Pinellia tuber total organic acid and extraction method, and its use in preparing drugs
11/08/2006	CN1283318C Medicinal preparation of slowly-released bioactive substance, its prepn. and application
11/08/2006	CN1283317C Use of opioid kappa receptor-excited compound in preparing pharmaceuticals for treating septicemia
11/08/2006	CN1283316C Attenuated live vaccine of vibrion from eel
11/08/2006	CN1283308C Chinese medicime liposome for treating viral hepatitis B and preventing liver cell from fibriform and preparing method thereof
11/08/2006	CN1283307C Combination of Chinese traditional medicine for treating tuberculosis
11/08/2006	CN1283306C Traditional Chinese medicine capsule for treating tuberculosis and neo-last-cough
11/08/2006	CN1283304C Quality control method for composite Chinese medicine for treating bloat
11/08/2006	CN1283298C Pharmaceutical composition for treating acute myocardial ischemia its preparing method
11/08/2006	CN1283277C Pharmaceutical composition for treating cold
11/08/2006	CN1283264C Staphylococcus aureus metabolic product medicine oral preparation and its use
11/08/2006	CN1283261C Water-soluble propolis liquor and its preparation method
11/08/2006	CN1283151C Synergic microbiocidal composition
11/07/2006	US7132541 Microbiocides
11/07/2006	US7132521 Molecular regulatory circuits to achieve sustained activation of genes of interest by a single stress
11/07/2006	US7132452 Useful for threapy of pain/inflammation associated with infection caused by herpes virus, especially herpes simplex virus (HSV) and varicella-zoster virus (VZV)
11/07/2006	US7132449 useful for the therapeutic treatment of Trypanosoma cruzi infection
11/07/2006	US7132447 Substance FKI-1083 and process for producing the same
11/07/2006	US7132443 Fluoropyrrolidines as dipeptidyl peptidase inhibitors
11/07/2006	US7132438 Benzimidazole derivatives
11/07/2006	US7132436 Inhibitors of 11-β-hydroxy steroid dehydrogenase type 1
11/07/2006	US7132429 Sulfonamido ether substituted imidazoquinolines
11/07/2006	US7132420 Aspartic protease inhibitors
11/07/2006	US7132416 Benzothiazepine and benzothiazepine derivatives with ileal bile acid transport (IBAT) inhibotory activity for the treatment hyperlipidaemia
11/07/2006	US7132408 Composition and method for inhibiting platelet aggregation
11/07/2006	US7132395 Contacting human rhinovirus with a polypeptide having a fragment of human rhinovirus major receptor (HRR) permit HRV to bind to the polypeptide; HRV is inhibited from infecting host cell.
11/07/2006	US7132246 Use of soluble cytokeratin-1-fragments in diagnostics and therapy
11/07/2006	US7132232 Diagnosing mammary gland cancer; obtain mammary gland fluid, detect preferential virus in fluid, evaluate for cancer
11/07/2006	US7132121 Inhibition of viral infection using antigen-binding proteins
11/07/2006	US7132118 Superoxide dismutase-containing cucumber extract coated and/or microencapsulated in a fat-soluble agent based on a fatty substance can be used by the topical or oral route; antiallergens; sunscreen agents; foods; drugs; cosmetics
11/07/2006	US7132108 Immunizing poultry from infection from Salmonella enteritidis by administering a total dose of killed S. enteritidis of 0.15 to 15 mg, administered as a single dose, of a suspension of microspheres comprising killed S. enteritidis encapsulated in porous poly(lactide-coglycolide) copolymer shell
11/07/2006	US7132101 Compositions and methods for eliciting an immune response to gram-negative bacterial infections
11/07/2006	CA2375093C Delivery system for oral care compositions comprising organosiloxane resins using a removable backing strip
11/02/2006	WO2006116557A1 Nucleoside compounds for treating viral infections
11/02/2006	WO2006116262A1 Use of vitamin e tocotrienols for the inhibition of intracellularly obligate pathogen chlamydia
11/02/2006	WO2006115509A2 Small molecule immunopotentiators and assays for their detection
11/02/2006	WO2006115423A1 Immune response inhibition using indole diterpene compound
11/02/2006	WO2006115413A2 Methods and means for the treatment of hpv induced intraepithelial neoplasias
11/02/2006	WO2006115353A1 A novel hydroxamic acid derivative as peptide deformylase inhibitor and manufacturing method thereof
11/02/2006	WO2006115188A1 Heterocyclic compound
11/02/2006	WO2006115123A1 Virus-inactivating agent
11/02/2006	WO2006114709A1 Pharmaceutical compositions of antiretrovirals
11/02/2006	WO2006114652A1 Ethanolic extract of animal origin combined with enzymes acts therapeutically on malignant and other diseases.
11/02/2006	WO2006114630A1 Compositions for intestinal conditions
11/02/2006	WO2006114263A1 Imidazo [1, 2-a] pyridine derivatives useful as peptide deformylase (pdf) inhibitors
11/02/2006	WO2006114261A1 Imidazo(1,2-a)pyridine derivatives useful as peptide deformylase (pdf) inhibitors
11/02/2006	WO2006114042A1 Application of levo-ornidazole in preparation of anti-anaerobic bacteria infection medicine
11/02/2006	WO2006114001A1 Method for improving pharmacokinetics of protease inhibitors and protease inhibitor precursors
11/02/2006	WO2006089664A3 Heterocyclylamide-substituted imidazoles
11/02/2006	WO2006088790A3 Use of chlorine dioxide for the treatment of onychomycosis (nail fungus)
11/02/2006	WO2006087077A3 Hsp90-inhibiting triazole derivatives
11/02/2006	WO2006085337B1 Parenteral combination therpy for infective conditions with drug resistant bacterium
11/02/2006	WO2006059344B1 Compositions for combating beta-lactamase-mediated antibiotic resistance using beta-lactamase inhibitors useful for injection
11/02/2006	WO2005113515A8 Pyrimidines for use as plk inhibitors
11/02/2006	WO2005107748A3 Method of tonic treatment with oxyphenbutazone derivatives
11/02/2006	WO2005086814A3 Methods and compositions related to regulation of cytokine production by glycogen synthase kinase 3 (gsk-3)
11/02/2006	US20060247448 zearalenone-like macrolides, used to to inhibit nuclear factor kappa-beta (NF- kappa B) activation, as sucnscreen agents and in the treatment of inflammatory or autoimmune disorders and disorders involving malignancy or increased angiogenesis
11/02/2006	US20060247302 Novel compounds, pharmaceutical compositions containing same, and methods of use for same
11/02/2006	US20060247290 Derivatives of dioxan-2-alkyl carbamates, preparation thereof and application thereof in therapeutics
11/02/2006	US20060247286 Oxazolidinone antibiotics and derivatives thereof
11/02/2006	US20060247261 Pyrimidine compounds
11/02/2006	US20060247212 Heterocyclic compounds having inhibitory activity against HIV integrase
11/02/2006	US20060247199 Methods and products for manipulating uncoupling protein expression
11/02/2006	US20060247184 Treatment and prophylaxis of diseases and infections pigs and poultry
11/02/2006	US20060247176 Recombinant expression system for production of a peptide capable of inhibiting the protease activity of Botulinum toxin B or tetanus toxin which expression system comprises a nucleotide sequence encoding the peptide operably linked to a control sequence for effecting expression
11/02/2006	US20060247161 Use of active ingredients for the prophylaxis and/or therapy of viral diseases
11/02/2006	US20060246587 Methods for transfecting T cells
11/02/2006	US20060246486 Human signal peptide-containing proteins
11/02/2006	US20060246110 Sustained release pharmaceutical composition
11/02/2006	US20060246092 Immunoprotective influenza antigen and its use in vaccination
11/02/2006	US20060246090 Vaccine against hcv
11/02/2006	US20060246089 Immunogen for preparation of therapeutic vaccines or drugs for treatment of hepatitis b and the producing method and use thereof
11/02/2006	US20060246088 Use of HIV-1 gp120 and gp160 proteins modified in the V3 loop for the preparation of vaccine compositions and formulations containing the same
11/02/2006	US20060246087 A fusion monomer of fusion protein of an antigen derived from an envelope protein of Japanese encephalitis virus and an amino acid sequence of a mucous membrane-binding protein monomer; industrial scale; purification efficiency; recombinant mucosal vaccine; intestinal immunization by oral administration
11/02/2006	US20060246085 Methods for manipulating satiety
11/02/2006	US20060246042 Cells, culture methods, and their use in autologous transplantation therapy
11/02/2006	US20060246038 Method of treating a disorder by suicide gene therapy
11/02/2006	US20060246035 Methods and products related to treatment and prevention of hepatitis c virus infection
11/02/2006	US20060246012 Delivery of physiologically active compounds through an inhalation route
11/02/2006	US20060246011 Delivery of diphenhydramine through an inhalation route
11/02/2006	EP1717238A1 Fungicidal heterocyclic compounds
11/02/2006	EP1717226A1 2,7-substituted 5-amino-4-hydroxy-8-(1h-indol-5-yl)-octan amide derivatives as renin inhibitors for the treatment of hypertension
11/02/2006	EP1717225A1 Bicyclic amide derivatives
11/02/2006	EP1716862A1 Bactericide against streptococcus mutans and streptococcus sobrinus
11/02/2006	EP1716855A1 Remedy for external use for skin and mucosal injuries caused by viral infection
11/02/2006	EP1716178A1 Less immunogenic binding molecules
11/02/2006	EP1716162A1 Phosphonates, monophosphonamidates, bisphosphonamidates for the treatment of viral diseases
11/02/2006	EP1716156A2 Chemokine ccr5 receptor modulators
11/02/2006	EP1716101A1 Aromatic a-ring derivatives of tetracycline compounds
11/02/2006	EP1715879A1 Onion extracts
11/02/2006	EP1715873A1 Nucleoside phosphonate derivatives useful in the treatment of hiv infections
11/02/2006	EP1715855A2 Anti-viral therapeutics
11/02/2006	EP1660068A4 Composition for treatment of tinea pedis and method of use
11/02/2006	EP1644410A4 Sushi peptide multimer
11/02/2006	EP1631575B1 NEW 3-DECLADINOSYL 9a-N -CARBAMOYL AND 9a-N -THIOCARBAMOYL DERIVATIVES OF 9-DEOX-9-DIHYDRO-9a-AZA-9A-HOMOERYTHROMYCIN A
11/02/2006	EP1578723A4 Process for the preparation of oxazolidinones and method of use thereof
11/02/2006	EP1485040B1 Method of administering an injectable antibiotic to the ear of an animal
11/02/2006	EP1474172B1 Pharmaceutical compositions for hepatitis c viral protease inhibitors
11/02/2006	EP1446394B1 Novel 1,2,4-thiadiazole derivatives as melanocortin receptor modulators
11/02/2006	EP1434624B1 2-amino-6-(2,4,5-substituted-phenyl)-pyridines for use as nitric oxide synthase inhibitors

1 ... 851 852 853 854 855 856 857 858 859 860 861 862 863 864 865 866 867 868 869 870 871 ... 1798